Chemical enhancer solubility in human stratum corneum lipids and enhancer mechanism of action on stratum corneum lipid domain

被引:44
|
作者
Ibrahim, Sarah A. [1 ]
Li, S. Kevin [1 ]
机构
[1] Univ Cincinnati, Coll Pharm, Div Pharmaceut Sci, Cincinnati, OH 45267 USA
关键词
Chemical enhancers; Transdermal; Extracted human stratum corneum lipids; DSC and ATR-FTIR; TRANSFORM INFRARED-SPECTROSCOPY; SKIN PERMEATION ENHANCERS; TRANSDERMAL DELIVERY-SYSTEM; HUMAN EPIDERMAL MEMBRANE; ATR-FTIR SPECTROSCOPY; HAIRLESS MOUSE SKIN; IN-VITRO; PENETRATION ENHANCERS; ELECTRON-MICROSCOPY; CHAIN;
D O I
10.1016/j.ijpharm.2009.09.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Previously, chemical enhancer-induced permeation enhancement on human stratum corneum (SC) lipoidal pathway at enhancer thermodynamic activities approaching unity in the absence of cosolvents (defined as Emax) was determined and hypothesized to be related to the enhancer solubilities in the SC lipid domain. The objectives of the present study were to (a) quantify enhancer uptake into SC lipid domain at saturation, (b) elucidate enhancer mechanism(s) of action, and (c) study the SC lipid phase behavior at Emax. It was concluded that direct quantification of enhancer uptake into SC lipid domain using intact SC was complicated. Therefore a liposomal model of extracted human SC lipids was used. In the liposome study, enhancer uptake into extracted human SC lipid liposomes (EHSCLL) was shown to correlate with Emax. Attenuated total reflectance Fourier transform infrared spectroscopy (ATR-MR) and differential scanning calorimetry, (DSC) were used to evaluate lipid phase alterations in enhancer-treated intact SC. IR spectra demonstrated an increase in the lipid domain fluidity and DSC thermograms indicated a decrease in the phase transition temperature with increasing Emax. These results suggest that the enhancer mechanism of action is through enhancer intercalation into SC intercellular lipids and subsequent lipid lamellae fluidization related to enhancer lipid concentration. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 98
页数:10
相关论文
共 50 条
  • [1] Stratum corneum lipid liposomes for investigating skin penetration enhancer effects
    Bakonyi, Monika
    Gacsi, Attila
    Berko, Szilvia
    Kovacs, Anita
    Csanyi, Erzsebet
    RSC ADVANCES, 2018, 8 (48) : 27464 - 27469
  • [2] Chemical Enhancer: A Simplistic Way to Modulate Barrier Function of the Stratum Corneum
    Haque, Tasnuva
    Talukder, Md Mesbah Uddin
    ADVANCED PHARMACEUTICAL BULLETIN, 2018, 8 (02) : 169 - 179
  • [3] Skin Diseases Associated with the Depletion of Stratum Corneum Lipids and Stratum Corneum Lipid Substitution Therapy
    Sahle, Fitsum F.
    Gebre-Mariam, Tsige
    Dobner, Bodo
    Wohlrab, Johannes
    Neubert, Reinhard H. H.
    SKIN PHARMACOLOGY AND PHYSIOLOGY, 2015, 28 (01) : 42 - 55
  • [4] STRATUM-CORNEUM LIPIDS
    ELIAS, PM
    JOURNAL OF THE SOCIETY OF COSMETIC CHEMISTS, 1982, 33 (07): : 373 - 373
  • [5] UPTAKE OF LIPIDS INTO HUMAN STRATUM-CORNEUM
    INAGI, T
    HIGUCHI, WI
    ANDERSON, BD
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (11) : S51 - S51
  • [6] Proposed human stratum corneum water domain in chemical absorption
    Zhu, Hanjiang
    Jung, Eui-Chang
    Hui, Xiaoying
    Maibach, Howard
    JOURNAL OF APPLIED TOXICOLOGY, 2016, 36 (08) : 991 - 996
  • [7] SOLUBILITY OF ORGANIC-MOLECULES IN LIPIDS OF STRATUM-CORNEUM
    SCHEUPLEIN, RJ
    KING, PN
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1975, 64 (03) : 209 - 209
  • [8] ENHANCER SYSTEMS - FLUORESCENCE SPECTROSCOPIC EVALUATION OF STRATUM-CORNEUM LIPIDS - IMPLICATIONS FOR PERMEATION ENHANCEMENT
    POTTS, RO
    AZIMI, NA
    SPENCER, TS
    LYTTLE, FE
    CHEN, DA
    ACTA PHARMACEUTICA NORDICA, 1992, 4 (02): : 121 - 121
  • [9] SOLUBILITY OF ORGANIC-MOLECULES IN LIPIDS OF STRATUM-CORNEUM
    SCHEUPLEIN, RJ
    KING, PN
    CLINICAL RESEARCH, 1975, 23 (03): : A455 - A455
  • [10] The detailed lipid composition in human stratum corneum
    Van Smeden, J.
    Hankemeijer, T.
    Vreeken, R. J.
    Bouwstra, J. A.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (06) : 807 - 807